Hope Pharmaceuticals et al., 2025-11-17: The approved U.S. cyanide antidote kit is sodium nitrite plus sodium thiosulfate; methylene blue is not part of it.
NITHIODOTE, an antidote, is indicated for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening.
1
Hope Pharmaceuticals et al., 2025-11-17: The approved U.S. cyanide antidote kit is sodium nitrite plus sodium thiosulfate; methylene blue is not part of it. C9. The current approved cyanide antidote in this label is the nitrite-thiosulfate pair, not methylene blue. The same label carries a boxed warning that sodium nitrite itself causes hypotension and methemoglobin formation, which is where methylene blue enters cyanide care – as the treatment for nitrite-induced methemoglobinemia, not as the cyanide antidote. Label holder Hope Pharmaceuticals; SPL published 2025-11-17. Quote from section 1 (Indications and Usage), PDF page 1. Bearing CONTRADICTS the claim that methylene blue is a recommended cyanide antidote today; the label shows what is recommended instead. Also filed as MTI-16 (claims C2, C9). Study type: regulatory record.
